Wei Zhu

ORCID: 0009-0001-3077-6518
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Treatment and Pharmacology
  • Osteoarthritis Treatment and Mechanisms
  • Extracellular vesicles in disease
  • Synthetic Organic Chemistry Methods
  • Cancer, Hypoxia, and Metabolism
  • Mesenchymal stem cell research
  • Microbial Natural Products and Biosynthesis
  • Nanoplatforms for cancer theranostics
  • Anesthesia and Neurotoxicity Research
  • Indoor Air Quality and Microbial Exposure
  • Corneal surgery and disorders
  • Bone and Joint Diseases
  • Corneal Surgery and Treatments
  • Genomics, phytochemicals, and oxidative stress
  • Glaucoma and retinal disorders
  • Geochemistry and Elemental Analysis
  • Silk-based biomaterials and applications
  • Nanoparticle-Based Drug Delivery
  • Skin Protection and Aging
  • Inflammatory Biomarkers in Disease Prognosis
  • Microtubule and mitosis dynamics
  • Knee injuries and reconstruction techniques
  • 14-3-3 protein interactions
  • Nanoparticles: synthesis and applications
  • Acute Ischemic Stroke Management

Chinese Academy of Medical Sciences & Peking Union Medical College
2022-2023

Tianjin Huanhu Hospital
2023

Anhui Provincial Hospital
2023

Peking Union Medical College Hospital
2022-2023

Xuan Wu Hospital of the Capital Medical University
2021

Baotou Medical College
2020

Shandong Provincial Hospital
2017

Jinan Central Hospital
2017

Shandong University
2017

University of Pittsburgh
2010-2011

The dictyostatins are a promising class of potential anti-cancer drugs because they powerful microtubule-stabilizing agents, but the complexity their chemical structures is severe impediment to further development. On basis both synthetic and medicinal chemistry analyses, 16-desmethyl-25,26-dihydrodictyostatin its C6 epimer were chosen as potentially potent yet accessible dictyostatin analogues, three new syntheses developed. A relatively classical synthesis involving vinyllithium addition...

10.1021/ja103537u article EN Journal of the American Chemical Society 2010-06-14

Introduction: Rare-earth nanoparticles in the environment and human body pose a potential threat to health. Although toxic effects of rare-earth have been extensively studied, on early development are not well understood. In this study, we attempted explain neodymium oxide (Nd 2 O 3 ) development. Methods: We added Nd at different concentrations recorded mortality malformation rate per 24 hrs under microscope. The live embryos treated with were imaged as movies Z step lapses confocal...

10.2147/ijn.s220785 article EN cc-by-nc International Journal of Nanomedicine 2020-01-01

The natural product (--)-dictyostatin is a microtubule-stabilizing agent that potently inhibits the growth of human cancer cells, including paclitaxel-resistant clones. Extensive structure-activity relationship studies have revealed several regions molecule can be altered without loss activity. most potent synthetic dictyostatin analogue described to date, 6-epi-dictyostatin, has superior in vivo antitumor activity against breast xenografts compared with paclitaxel. In spite their...

10.1158/1535-7163.mct-10-1048 article EN Molecular Cancer Therapeutics 2011-04-14

The dictyostatins are powerful microtubule-stabilizing agents that have shown antiproliferative activity against a variety of human cancer cell lines. Two highly active analogs dictyostatin, 25,26-dihydrodictyostatin and 25,26-dihydro-6-epi-dictyostatin, were prepared by new streamlined total synthesis route. Three complete carbon fragments to achieve maximum convergency. These coupled Horner-Wadsworth-Emmons reaction sequence an esterification. A late stage Nozaki-Hiyama-Kishi was then used...

10.3762/bjoc.7.161 article EN cc-by Beilstein Journal of Organic Chemistry 2011-10-05

Abstract Background Hypoxia-mediated radioresistance is the main obstacle to successful treatment of glioblastoma (GBM). Enhancing hypoxic radiosensitivity and alleviating tumor hypoxia are both effective means improve therapeutic efficacy, combination two highly desirable meaningful. Results Herein, we construct a low-dose pleiotropic radiosensitive nanoformulation consisting high-Z atomic nanocrystal core mesoporous silica shell, surface-modified with angiopep-2 (ANG) peptide loaded nitric...

10.1186/s12645-023-00159-w article EN cc-by Cancer Nanotechnology 2023-02-04

Acute photodamage is an acute inflammatory reaction of the skin after ultraviolet (UV) irradiation. Many drugs have been successfully used for treatment and prevention photodamage.To evaluate molecular mechanism N-terminal 5-mer peptide analog P165 amyloid precursor protein in repairing photodamaged rat skin.We establish a model UVB photodamage. The ratskin was treated with or without 250, 500, and, 1000 μM P165. Histological analysis performed by hematoxylin eosin staining. Apoptotic cells...

10.4103/ijd.ijd_1146_20 article EN cc-by-nc-sa Indian Journal of Dermatology 2021-09-01

Background. This study is aimed at investigating the relationship between neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte (PLR), and hyperhomocysteinemia (HHCY) in patients with ischemic stroke (IS). Methods. retrospectively analyzed clinical data laboratory results of 110 IS patients. According to cut-off value <math xmlns="http://www.w3.org/1998/Math/MathML" id="M1"> <mtext>HCY</mtext> <mo>=</mo> <mn>15</mn> <mtext> </mtext> <mi>μ</mi> <mtext>mol</mtext> <mo>/</mo>...

10.1155/2023/6642768 article EN Acta Neurologica Scandinavica 2023-09-19

Objective To evaluate the safety and efficacy of epithelium-off corneal collagen cross-linking (CXL) induced by riboflavin ultraviolet A light for keratoconus in teenagers. Methods The medical records consecutive patients (30 eyes 19 cases) at age 14-18 years treated with CXL were analyzed this retrospective self-control study. Data from preperative 3-, 6-, 12-month postoperative examinations one way repeated ANOVA. The clinical evaluations included uncorrected visual acuity (UCVA),...

10.3760/cma.j.issn.1674-845x.2017.05.007 article EN Chinese Journal of Optometry & Ophthalmology 2017-05-25
Coming Soon ...